Rick Riegel became the Executive Chairman of ActiGraph after the company received private equity investment in May 2020. He is the former Chief Executive Officer and current Vice Chairman of the Board of Phlexglobal, Inc., a global provider of specialized technology and expert services solutions for the pharmaceutical and life sciences industry across the Trial Master File, Clinical and Regulatory processes. Under his four years of leadership, Phlexglobal grew significantly, improved profitability, established a significant services operation in Poland, and he led the sale process to new private equity ownership.

Riegel is also a member of the Board of Directors of private equity backed Syner-G Pharm Consulting and is on the external Board of Advisors of ArisGlobal and Gens & Associates. Previously, as CEO of LIQUENT, he managed the divestiture of LIQUENT out of Thomson Reuters to private equity ownership, and after transforming the company to higher growth and profitability, led the sale of LIQUENT to PAREXEL, a leading Clinical Research Organization.

Throughout his 30-plus year career, Riegel has held key positions with increasing responsibilities in the technology and professional services industries as a CEO, vice president, general manager, and head of sales, supporting companies in the pharmaceutical and life sciences industries and in addition to his more recent roles, he worked for companies including IBM, First Consulting Group, Taratec Development and Barnett International. Riegel earned a Master of Business Administration degree from Villanova University and a Bachelor of Science degree in Mechanical Engineering from Penn State.